Table 3.
Visual and headache outcomes for medically managed IIH patients
| Months | |||||
|---|---|---|---|---|---|
| 0 | 6 | 12 | 24 | 36 | |
| LogMAR visual acuity, logunits (mean (SD), n) | 0.04 (0.16), 337 | 0.02 (0.21), 175 | 0.00 (0.16), 147 | − 0.03 (0.13), 96 | − 0.04 (0.14), 59 |
| Humphrey visual field perimetric mean deviation, dB (mean (SD), n) | − 3.38 (3.44), 351 | − 2.72 (4.50), 168 | − 2.03 (4.01), 134 | − 2.19 (3.08), 90 | − 2.18 (3.22), 49 |
| Global peripapillary retinal nerve fibre layer, µm (mean (SD), n) | 127.3 (39.0), 277 | 118.6 (45.8), 136 | 120.8 (40.0), 110 | 106.4 (31.3), 74 | 103.4 (33.1), 48 |
| Global peripapillary total retinal thickness, µm (mean (SD), n) | 360.5 (56.2), 277 | 342.5 (64.8), 136 | 343.1 (57.4), 110 | 327.2 (44.6), 74 | 318.1 (48.9), 48 |
| Macular ganglion cell layer volume, mm3 (mean (SD), n) | 0.439 (0.031), 327 | 0.441 (0.035), 151 | 0.443 (0.030), 118 | 0.434 (0.024), 81 | 0.436 (0.026), 51 |
| Headache frequency, days/month (mean (SD), n) | 21.0 (12.2), 304 | 19.2 (14.0), 146 | 19.1 (12.4), 127 | 16.6 (10.2), 85 | 16.1 (11.4), 53 |
| Migraine-like headache frequency, days/month (mean (SD), n) | 10.0 (8.6), 224 | 8.8 (9.5), 104 | 7.9 (9.1), 94 | 8.4 (7.3), 67 | 8.0 (8.2), 45 |
| Headache severity, visual analogue scale 0–10 (mean (SD), n) | 6.3 (2.9), 304 | 5.7 (3.6), 154 | 5.8 (3.0), 130 | 5.9 (2.6), 89 | 5.5 (2.9), 58 |
| Headache Impact Test 6, score 36–78 (mean (SD), n) | 55.7 (15.7), 197 | 57.6 (17.6), 107 | 55.7 (17.5), 107 | 58.6 (14.6), 76 | 59.5 (15.7), 44 |